This has been a year of innovation and achievement at the Helen Diller Family Comprehensive Cancer Center. Our dedicated clinicians, curious researchers, and inspired philanthropists joined forces with patients and families, community groups, and government and industry partners to improve the quality of cancer prevention, treatment, and survivorship. As the year winds down, we take a moment to reflect on some highlights. [read more]
|
|
|
|
Arnold Perkins has retired after 17 years participating on – and nine years leading – the Cancer Center’s Community Advisory Board (CAB). Perkins, 80, was a founding member of the CAB, launched in 2005. |
|
|
|
Using new machine learning techniques, researchers at UCSF and IBM Research have developed a virtual molecular library of “words” that encode commands to kill cancer cells. |
|
|
|
A longtime friend and supporter of UCSF, Art served on the Foundation Board of Directors for 21 years, holding numerous leadership positions, and on the Cancer Leadership Council.
|
|
Salma Shariff-Marco, PhD, MPH and Iona Cheng, PhD, MPH received an R01 award funded by National Institute on Minority Health and Health Disparities for a project, "Understanding the impact of structural racism on racial/ethnic inequities in mortality: The Multiethnic Cohort Study."
Erin Van Blarigan, ScD and team received an American Institute for Cancer Research (AICR) Investigator-Initiated Research Grant for a project, "Health behaviors and colorectal cancer survival in the Multiethnic Cohort Study."
|
|
Spanogiannopoulos P, Kyaw TS, Guthrie BGH, Bradley PH, Lee JV, Melamed J, Malig YNA, Lam KN, Gempis D, Sandy M, Kidder W, Van Blarigan EL, Atreya CE, Venook A, Gerona RR, Goga A, Pollard KS, Turnbaugh PJ. Host and gut bacteria share metabolic pathways for anti-cancer drug metabolism. Nat Microbiol. 2022 Oct;7(10):1605-1620.
Tolani B, Celli A, Yao Y, Tan YZ, Fetter R, Liem CR, de Smith AJ, Vasanthakumar T, Bisignano P, Cotton AD, Seiple IB, Rubinstein JL, Jost M, Weissman JS. Ras-mutant cancers are sensitive to small molecule inhibition of V-type ATPases in mice. Nat Biotechnol. 2022 Dec;40(12):1834-1844.
|
|
Cervical cancer is preventable, treatable, and beatable. Throughout the month of January, HDFCCC's Office of Community Engagement (OCE) staff and partners will raise awareness of cervical cancer, screening, and HPV vaccination through community events, website, and social media posts.
|
|
|
Feb 1, 2023 | 9:00 am - 1:00 pm
Provides an opportunity to have short interviews with post-bacc trainees interested in a research career and eligible to apply for a NIH diversity supplement. Diversity Supplements generally provide enough salary for the trainee to work 1-2 years as a Junior Specialist. Trainees who make a match may apply to the UCSF PROPEL Program. Faculty who are not eligible to apply for diversity supplements but have other funds to hire a research assistant can still attend. Register by Jan 6.
|
|
Now accepting applications for Office of Education & Training Postdoc Travel Grants. Two grants of up to $1500 will be given. For one grant, priority is given to postdocs from historically underrepresented groups. You must work in an HDFCCC member's lab and must be attending a cancer specific conference. Learn more and apply by Jan 23.
|
|
Javid Moslehi, MD (UCSF) will present, "Cardio-Oncology: A New Clinical Frontier and a Novel Platform for Investigation."
All are invited to join a candle lighting event to celebrate the Jewish holiday Chanukah.
This three-day conference features tracks on Emerging Therapeutics, AI & Data Sciences, Diagnostics & Molecular Profiling in the Clinic, and Next Generation Technologies.
A leadership and career development seminar for senior fellows and early career faculty.
A leadership and career development seminar for senior fellows and early career faculty.
|
|
|
|
|
|
|
